Clinical Trial Using Real World Data
نویسندگان
چکیده
منابع مشابه
Improving Realism in Clinical Trial Simulations via Real‐World Data
Simulation validity depends on how well sampling distributions used reflect real-patient characteristics, such as drug adherence, disease progression, and pharmacologic handling in the body. We challenge the current use of growth charts from nondisease-specific pediatrics in simulations for drug development. Complementary use of data from clinical trials and the real-world is expected to achiev...
متن کاملIndexing Real - World Data using Semi - Structured
We address the problem of deriving meaningful semantic index information for a multi-media database using a semi-structured document model. We show how our framework, called feature grammars, can be used to (1) exploit third-party interpretation modules for real-world unstructured components, and (2) use context-free grammars to convert such poorly or unstructured input to semi-structured outpu...
متن کاملCrash Visualization Using Real - World Acceleration Data
Vehicle crash-event data recorders associated with inflatable occupant restraint systems, Mayday systems, and Automatic Crash Notification systems are rapidly becoming more common and more sophisticated. If such devices are equipped with integral accelerometers, it is possible to input the actual vehicle accelerationtime history recorded during the crash to a suitable occupant dynamics computer...
متن کاملReal-world data confirm clinical trial outcomes for rivaroxaban in orthopaedic patients
Venous thromboembolism (VTE) is a potential cause of morbidity and mortality in patients after major orthopaedic surgery. Based on the results of the international phase III RECORD (Regulation of Coagulation in Orthopaedic Surgery to Prevent Deep Vein Thrombosis and Pulmonary Embolism) program, the oral, direct Factor Xa inhibitor rivaroxaban has been approved in many countries for the preventi...
متن کاملUsing real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.
OBJECTIVES Health decision-makers involved with coverage and payment policies are increasingly developing policies that seek information on "real-world" (RW) outcomes. Motivated by these initiatives, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) created a Task Force on Real-World Data to develop a framework to assist health-care decision-makers in dealing with RW...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Journal of Lung Cancer
سال: 2022
ISSN: ['0386-9628', '1348-9992']
DOI: https://doi.org/10.2482/haigan.62.965